Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$332M |
| 2 |
ExxonMobil
XOM
|
+$283M |
| 3 |
Verizon
VZ
|
+$165M |
| 4 |
Yum China
YUMC
|
+$137M |
| 5 |
Chevron
CVX
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$941M |
| 2 |
Dimensional International Core Equity 2 ETF
DFIC
|
+$862M |
| 3 |
Dimensional International High Profitability ETF
DIHP
|
+$427M |
| 4 |
Dimensional International Small Cap Value ETF
DISV
|
+$421M |
| 5 |
Apple
AAPL
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.74% |
| 2 | Technology | 15.25% |
| 3 | Industrials | 12.58% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Discretionary | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTN
3301
Palatin Technologies
PTN
$13M
| $135K | ﹤0.01% |
+458
| New | +$151K |
|
3302
Globalstar
GSAT
$10.1B
| $133K | ﹤0.01% |
5,563
+950
| +21% | +$22.9K |
|
3303
Vor Biopharma
VOR
$1.03B
| $131K | ﹤0.01% |
+1,647
| New | +$162K |
|
|
SRNE
3304
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $129K | ﹤0.01% |
82,204
| – | – |
|
3305
Savara
SVRA
$1.08B
| $126K | ﹤0.01% |
81,408
-14,786
| -15% | -$23.8K |
|
3306
Precision BioSciences
DTIL
$181M
| $125K | ﹤0.01% |
3,190
-2,686
| -46% | -$128K |
|
|
KC
3307
Kingsoft Cloud Holdings
KC
$2.97B
| $123K | ﹤0.01% |
61,902
| – | – |
|
|
PVLA
3308
Palvella Therapeutics
PVLA
$2.01B
| $123K | ﹤0.01% |
1,333
-435
| -25% | -$56.1K |
|
3309
Werewolf Therapeutics
HOWL
$21.5M
| $117K | ﹤0.01% |
+25,996
| New | +$141K |
|
3310
Oxbridge Re Holdings
OXBR
$13M
| $117K | ﹤0.01% |
54,753
| – | – |
|
3311
SelectQuote
SLQT
$127M
| $117K | ﹤0.01% |
161,127
+19,929
| +14% | +$33.1K |
|
3312
Sono-Tek
SOTK
$77.6M
| $117K | ﹤0.01% |
16,725
+4,386
| +36% | +$27.7K |
|
3313
Harte-Hanks
HHS
$17.6M
| $115K | ﹤0.01% |
+10,348
| New | +$138K |
|
3314
Sypris Solutions
SYPR
$44.2M
| $115K | ﹤0.01% |
61,481
+304
| +0.5% | +$615 |
|
3315
Aveanna Healthcare
AVAH
$2.12B
| $114K | ﹤0.01% |
75,899
-38,360
| -34% | -$78.8K |
|
|
OTIC
3316
DELISTED
Otonomy, Inc.
OTIC
| $112K | ﹤0.01% |
381,902
-507,377
| -57% | -$445K |
|
3317
US Gold Corp
USAU
$209M
| $109K | ﹤0.01% |
29,083
-1,810
| -6% | -$7.12K |
|
|
ALP
3318
Alpha Compute
ALP
$4.58M
| $107K | ﹤0.01% |
+784
| New | +$130K |
|
|
IMMP
3319
Immutep
IMMP
$56.7M
| $106K | ﹤0.01% |
68,386
+10,551
| +18% | +$21.5K |
|
3320
Nortech Systems
NSYS
$40.5M
| $106K | ﹤0.01% |
+10,056
| New | +$126K |
|
3321
Taylor Devices
TAYD
$177M
| $105K | ﹤0.01% |
+10,297
| New | +$95.4K |
|
3322
Anixa Biosciences
ANIX
$116M
| $104K | ﹤0.01% |
+21,177
| New | +$85.8K |
|
3323
Abeona Therapeutics
ABEO
$333M
| $103K | ﹤0.01% |
+33,983
| New | +$140K |
|
3324
Biomerica
BMRA
$4.85M
| $102K | ﹤0.01% |
3,259
| – | – |
|
3325
Cineverse
CNVS
$59M
| $102K | ﹤0.01% |
12,928
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Dimensional Fund Advisors held 3,606 positions worth $260B, down 6.6% from $279B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q3 2022 filing shows 143 new, 1,920 increased, 1,329 reduced and 119 closed positions. Its largest new stake was Yum China: 2,857,283 shares worth $135M. The largest sale was Dimensional Emerging Markets Core Equity 2 ETF, an estimated $941M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- Dimensional Fund Advisors's largest Q3 2022 buy was Yum China: 2,857,283 shares worth $135M.
- Dimensional Fund Advisors added most to Meta Platforms (Facebook) in Q3 2022, an estimated $332M increase.
- Dimensional Fund Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $219M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Core Equity 2 ETF in Q3 2022, selling an estimated $941M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $260B portfolio in Q3 2022.
- Dimensional Fund Advisors opened 143 new positions and closed 119 in Q3 2022.
- Dimensional Fund Advisors's portfolio value fell 6.6% quarter-over-quarter to $260B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.